RE:RE:Cheap Valuationwofats wrote: They just keep adding value .
The quarters, from now on, are up agaist their own numbers . 65 in sales from ths last quarter should translate into almost 280 revenue for the year. There should not be any surprises in expenses . Operating income shouldl start to show if they know what they are doing now.
As 300+ in sales are passed interest should increase .
They are continuing to buy back shares and that eventually should help the share price .They are showing it has value. If they were not buying back shares I would be worried .
As long as this investment is kept in proportion to the risk part of your portfolio,who cares how long it takes . I think those who expected a quick bang for their bucks will have a hard time accepting this investment . Accumulate on the dips . 5.11 is a good number ..
Someone will be right Mugs or Porky. Time will tell .
| iled 2023-02-03 10:50 Tx date 2023-01-31 | $GUD
Knight Therapeutics Inc. | Knight Therapeutics Inc. 1 - Issuer Direct Ownership | Common Shares 38 - Redemption, retraction, cancellation, repurchase |
-827,300 vol | 74,600 |
Hahaha - Porky and I aren't even talking about the same things.
He's still sad that Meir's gone.
He can't stand that GUD was built in PLB's image and there was no way to stop it.
Still not sure why he thinks my accuracy is a downfall.
---------------
GUD is the same execution - just at a larger scale, and in a different part of the world.
This one is so easy to read that it's a blessing to get to play a Goodman company twice in a lifetime.
Love a good Groundhog Day !!!!